EPISODE · Nov 8, 2024 · 17 MIN
Richard Lafayette, MD, FACP - Novel Therapies in Focus: Updates in IgA Nephropathy
from PeerVoice Internal Medicine Audio · host PeerVoice
Richard Lafayette, MD, FACP - Novel Therapies in Focus: Updates in IgA Nephropathy
What this episode covers
Visit https://www.peervoice.com/CZH860 to view the entire programme with slides. After completing “Richard Lafayette, MD, FACP - Novel Therapies in Focus: Updates in IgA Nephropathy”, participants will be able to: Distinguish between the clinical trials examining new and emerging therapies in IgA nephropathy (IgAN); Recognize the mechanistic rationale for targeting the drivers of immunopathogenesis in IgAN; and Evaluate clinical evidence and data regarding emerging therapies in patients with IgAN.
NOW PLAYING
Richard Lafayette, MD, FACP - Novel Therapies in Focus: Updates in IgA Nephropathy
No transcript for this episode yet
Similar Episodes
Mar 26, 2026 ·1m
Feb 8, 2026 ·4m
Jan 30, 2026 ·6m
Jan 2, 2026 ·47m